¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cement base"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • base exchange
    ¿°±â±³È¯
  • base of heart
    ½ÉÀå¹Ù´Ú, ½ÉÀåÀúºÎ
  • base of skull
    ¸Ó¸®»À¹Ù´Ú, µÎ°³Àú
  • base pair
    ¿°±â½Ö
  • base pair substitution
    ¿°±â½Öġȯ
  • base pairing
    ¿°±â¦Áþ±â
  • base unit
    ±âº»´ÜÀ§
  • buffer base
    ¿ÏÃæ¿°±â
  • conjugate base
    ¦¿°±â
  • cast base porcelain crown
    ÁÖÁ¶±âÄ¡°ü, ±âÀúºÎÁÖÁ¶µµÄ¡°ü
  • monoacidic base
    Àϻ꿰±â
  • negative base excess
    ¿ª¿°±â°úÀ×
  • ointment base
    ¿¬°í±âÁ¦
  • purine base
    Ǫ¸°¿°±â
  • skull base approach
    ¸Ó¸®¹Ù´Ú¼ö¼úÁ¢±Ù¹ý, µÎ°³Àú¼ö¼úÁ¢±Ù¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • base curve
    ±âº»°î¼±
  • base excess
    ¿°±â°úÀ×
  • base exchange
    ¿°±âġȯ
  • base line
    ¹ÙÅÁ¼±, ±âÁؼ±
  • base pair
    ¿°±â½Ö
  • base pairing
    ¿°±â¦Áþ±â
  • base line shift
    ±âÁؼ±À̵¿
  • base pair substitution
    ¿°±â½Ö´ëÄ¡
  • buffer base
    ¿ÏÃæ¿°±â
  • conjugate base
    ¦¿°±â
  • monoacidic base
    Àϻ꿰±â
  • ointment base
    ¿¬°í±âÁ¦
  • purine base
    Ç»¸°¿°±â
  • vitreous base
    À¯¸®Ã¼¹Ù´Ú, À¯¸®Ã¼±âÀú
  • walking base
    º¸Æø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • potassium cyanide broth base
    û»êÄ®·ý¾×ü±âÃʹèÁö
  • prism base-down
    ¹Ù´Ú¾Æ·¡ÇÁ¸®Áò
  • prism base-in
    ¹Ù´Ú³»ÃøÇÁ¸®Áò
  • prism base-out
    ¹Ù´Ú¿ÜÃøÇÁ¸®Áò
  • prism base-up
    ¹Ù´ÚÀ§ÇÁ¸®Áò
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary cement
    ÀÏÂ÷<Á¦ÀÏ>½Ã¸àÆ®Áú(ìéó­<ð¯ìé>¡­òõ).
  • prosthesis cement lucent line
    Àΰø¹° ½Ã¸àÆ® ¹æ»ç¼º Åõ°ú¼±
  • silicate cement
    ±Ô»ê¿°(Щ߫ç¤)½Ã¸àÆ®.
  • silver cement
    Àº½Ã¸àÆ®.
  • white cement
    ¹é»ö½Ã¸àÆ®, Èò»ö½Ã¸àÆ®.
  • zinc oxysulfate cement
    »êÈ­¾Æ¿¬À¯»ê(ß«ûù䬿çë©ß«)½Ã¸àÆ®.
  • zinc phosphate cement
    ÀÎ»ê¾Æ¿¬½Ã¸àÆ®.
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • acid-base compensation
    »ê¿°±â º¸»ó
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à
  • alveolar base
    Ä¡Á¶±âÀú(öÍðËÐñî¼).
  • apical base
    (Ä¡)±Ù÷(´Ü)±âÀú(¡­Ðñî¼).
  • arytenoid base
    ¸ð»Ô¿¬°ñ¹Ù´Ú
  • base
    ¿°±â
  • base (lining) applicators
    ÀÌÀå¿ë ±â±¸(ìÀíûéÄÐïÎý).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Base of cell
    ¼¼Æ÷¹Ù´Ú
    [¿¾ ¿ë¾î] ¼¼Æ÷Àú
  • Base of nail
    ¼ÕÅé¹Ù´Ú
    [¿¾ ¿ë¾î] Á¶±âÀú
  • Base of metacarpal bones
    ¼ÕÇ㸮»À¹Ù´Ú
    [¿¾ ¿ë¾î] Áß¼ö(Àå)°ñÀú
  • Base of heart
    ½ÉÀå¹Ù´Ú
    [¿¾ ¿ë¾î] ½ÉÀú
  • Base of sacrum
    ¾ûÄ¡»À¹Ù´Ú
    [¿¾ ¿ë¾î] õ°ñÀú
  • Base of prostate
    Àü¸³»ù¹Ù´Ú
    [¿¾ ¿ë¾î] Àü¸³¼±Àú
  • Base of modiolus
    Ãà¹Ù´Ú
    [¿¾ ¿ë¾î] ¿Í¿ìÃàÀú
  • Base of mandible
    ÅλÀ¹Ù´Ú
    [¿¾ ¿ë¾î] ÇϾÇÀú
  • Base of hair follicle
    ÅÐÁָӴϹٴÚ
    [¿¾ ¿ë¾î] ¸ð³¶Àú
  • Base of renal pyramid
    ÇǶó¹Ô¹Ù´Ú
    [¿¾ ¿ë¾î] ÃßüÀú
  • Base of lung
    ÇãÆÄ¹Ù´Ú
    [¿¾ ¿ë¾î] ÆóÀú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • base-pair substitution
    ¿°±â¦ ġȯ(öÇüµ)
  • base ratio
    ¿°±âºñ(ç¤ÐñÝï)
  • base sequence
    ¿°±â¼­¿­(ç¤ÐñßíÖª)
  • base specificity
    ¿°±âƯÀ̼º(ç¤Ðñ÷åì¶àõ)
  • base stacking
    ¿°±â(ç¤Ðñ) ½×ÀÓ
  • base substitution
    ¿°±âġȯ(ç¤ÐñöÇüµ)
  • Bronsted base
    ºê·Ð½ºÅ×µå ¿°±â(ç¤Ðñ)
  • complementary base pairing
    »óº¸¼º(ßÓÜÍàõ) ¿°±â(ç¤Ðñ) ¦Áþ±â
  • complementary base sequence
    »óº¸¼º ¿°±â¼­¿­(ßÓÜÍàõç¤ÐñßíÖª)
  • concerted acid-base catalysis
    Çùµ¿ »ê¿°±â Ã˸Å(úðÔÒß«ç¤ÐñõºØÚ)
  • conjugate acid-base pair
    ¦ÁöÀº »ê¿°±â½Ö(ß«ç¤Ðñäª)
  • general acid-base catalysis
    ÀϹÝ(ìéÚõ) »ê-¿°±â Ã˸Å(ß«-ç¤ÐñõºØÚ)ÀÛ¿ë
  • Hoogsten base pairs
    ÈŽºÆ¾ ¿°±â ½Ö(äª)
  • Lewis acid-base catalysis
    ·çÀ̽º »ê-¿°±â(ß«.ç¤Ðñ) Ã˸ÅÀÛ¿ë(ç¤Ðñ õºØÚÚãëë)
  • Lewis base
    ·çÀ̽º¿°±â(ç¤Ðñ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
bp base pair; ¿°±â½Ö
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
A/B acid-base ratio
AIDSDRUGS clinical trials of acquired immunodeficiency drugs [MEDLARS data base]
AIDSLINE on-line information on acquired immunodeficiency syndrome [MEDLARS data base]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
bp 1,000-base-pair
ABB Acid base balance
BE Base Excess
BER Base Excision Repair
BD Base deficit
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reinforced ZOE cement
    °­È­ »êÈ­ ¾Æ¿¬ À¯Áö³î ½Ã¸àÆ®
  • silicate cement
    ±Ô»ê¿° ½Ã¸àÆ®, ½Ç¸®ÄÉÀÌÆ® ½Ã¸àÆ®
    1. ºñ±³Àû ´Ü´ÜÇÑ, ¹ÝÅõ¸í¼ºÀÇ ¼öº¹ ¹°Áú·Î¼­ ÁÖ·Î ÀüÄ¡ºÎ¿¡ »ç¿ëµÈ´Ù. ¾×°ú ºÐ¸»À» È¥ÇÕÇÑ ÈÄ »ç¿ëÇϸç, ºÐ¸»Àº »êÈ­ Ä®½·, »êÈ­ ±Ô¼Ò, »êÈ­ ¾Ë·ç¹Ì´½ ¿Ü ±âŸ ±¸¼º ¼ººÐ°ú ºÒ¼Ò À¶Á¦¸¦ À¶ÇÕÇÏ¿© ¸¸µç »ê ¿ëÇØ¼ºÀÇ À¯¸®ÀÌ´Ù. ¾×Àº ¿ÏÃæ ÀÎ»ê ¿ë¾×ÀÌ´Ù. 2. ¾Ë·ç¹Ì³ë½Ç¸®ÄÉÀÌÆ® ±Û¶ó½º ºÐ¸»°ú ÀÎ»ê ¼ö¿ë¾×À» ¿¬È­ÇÏ¿© ÀÀ°á °æÈ­ÇÏ´Â Ä¡°ú¿ë ½Ã¸àÆ®.
  • white cement
    ¹é»ö ½Ã¸àÆ®, Èò»ö ½Ã¸àÆ®.
  • zinc oxide-ethoxybenzoic acid cement
    EBA ½Ã¸àÆ®
    »êÈ­ ¾Æ¿¬ À¯Áö³î ½Ã¸àÆ®ÀÇ ¾×Áß¿¡¼­ À¯Áö³îÀÇ ´ëºÎºÐÀ» EBA·Î ´ëüÇÑ Ä¡°ú¿ë ½Ã¸àÆ®.
  • zinc oxysulfate cement
    »êÈ­ ¾Æ¿¬ À¯»ê ½Ã¸àÆ®
  • zinc polycarboxylate cement
    ¾Æ¿¬ Æú¸®Ä«º¹½Ç·¹ÀÌÆ® ½Ã¸àÆ®
    »êÈ­ ¾Æ¿¬°ú Æú¸®¾ÆÅ©¸±»ê ¼ö¿ë¾×À» ¿¬È­ÇÏ¿© °æÈ­ÇÏ´Â Ä¡°ú¿ë ½Ã¸àÆ®.
  • zine oxide-eugenol dental cement
    »êÈ­¾Æ¿¬ À¯Áö³î
    °¡Àå ÀڱؼºÀÌ ÀûÀº ½Ã¸àÆ®ÀÌ´Ù. ºÐ¸»Àº »êÈ­ ¾Æ¿¬À» ±âº»À¸·Î °­È­Á¦¿Í ÃËÁøÁ¦¸¦ Æ÷ÇÔÇϸç, ¿ë¾×Àº À¯Áö³îÀÌ ±âº»ÀÌ´Ù.
  • acid-base
    »ê ¿°±â
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
  • acid-base indicator
    »ê ¿°±â Áö½Ã¾à
  • alveolar base
    Ä¡Á¶ ±âÀú
  • base applicator
    ÀÌÀå¿ë ±â±¸
  • base line
    ±â¼±, ±âÀú¼±, ¹ÙÅÁ¼±
    ¹ÌÁ¤ÀÇ ¾çÀ̳ª °ªÀ» ÃøÁ¤ ¶Ç´Â ÆòÁ¤ÇÏ´Â µ¥ ¾²ÀÌ´Â ±âº»ÀÇ ¾ç ¶Ç´Â °ª.
  • base line shift
    ±âÁؼ± º¯À§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
zinc oxide-eugenol cement Least irritating of the cements. The powder is essentially zinc oxide with strengtheners and accelerators. The liquid is basically eugenol. (boucher's clinical dental terminology, 4th ed, p50)
(12 Dec 1998)
zinc phosphate cement <chemical> A material used for cementation of inlays, crowns, bridges, and orthodontic appliances and occasionally as a temporary restoration. It is prepared by mixing zinc oxide and magnesium oxide powders with a liquid consisting principally of phosphoric acid, water, and buffers.
Chemical name: Phosphoric acid, zinc salt (2:3)
(12 Dec 1998)
unmodified zinc oxide-eugenol cement A dental cement obtained by mixing zinc oxide and eugenol without modifiers.
(05 Mar 2000)
acid-base balance The normal balance between acid and base in the blood plasma, expressed in the hydrogen ion concentration or pH, resulting from the relative amounts of acidic and basic materials ingested and produced by body metabolism, compared to the relative amounts of acidic and basic materials excreted from the body and consumed by body metabolism; the normal state of acid-base balance is not one of neutrality, with equal concentrations of hydrogen and hydroxyl ions, but a more alkaline state with a certain excess of hydroxyl ions.
Synonym: acid-base equilibrium.
(05 Mar 2000)
acid-base equilibrium A condition in which the net rate of acid or alkali production by the body is balanced by the net rate of acid or alkali excretion from the body, resulting in a stable concentration of hydrogen ions in the body fluids.
(12 Dec 1998)
acid-base imbalance Disturbances in the acid-base equilibrium of the body.
(12 Dec 1998)
acrylic resin base A form made of acrylic resin molded to conform to the tissues of the alveolar process and used to support the teeth of a prosthesis.
(05 Mar 2000)
aldehyde base An obsolete term for an imide.
(05 Mar 2000)
anterior cranial base The portion of the internal base of the skull, anterior to the sphenoidal ridges and limbus, in which the frontal lobes of the brain rest.
Synonym: fossa cranii anterior, anterior cranial base.
(05 Mar 2000)
Bandrowski's base <chemical> Reported cause of anaphylactic reaction.
Synonym: n',n'-bis(4-aminophenyl)-2,5-diamino-1,4-quinonediimine
(26 Jun 1999)
base <chemistry> The nonacid part of a salt, a substance that combines with acids to form salts, a substance that dissociates to give hydroxide ions in aqueous solutions, a substance whose molecule or ion can combine with a proton (hydrogen ion), a substance capable of donating a pair of electrons (to an acid) for the formation of a coordinate covalent bond.
(13 Nov 1997)
base analogue <biochemistry> A chemical which resembles a nucleotide base. They can substitute the Purine and pyrimidine bases that normally appear in DNA, despite minor differences in structure. May be used for inducing mutations, including point mutations.
For example: 5 bromouracil can replace thymine or 2 aminopurine replace adenine.
(13 Nov 1997)
base composition <biochemistry> In reference to nucleic acid, the proportion of the total bases consisting of guanine plus cytosine or thymine plus adenine base pairs.
Usually expressed as a guanine + cytosine (G+C) value, for example 60% G+C.
(09 Oct 1997)
base deficit A decrease in the total concentration of blood buffer base, indicative of metabolic acidosis or compensated respiratory alkalosis.
(05 Mar 2000)
base dissociation constant <chemistry> This is the equilibrium constant for the reaction in which a weak base breaks apart in water to form its conjugate acid and hydroxide ion.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • base exchange
    ¸ÅÁ¡
  • base hit
    ¾ÈŸ
  • base line
    ±âÁؼ±;´©¼±
  • base metal
    ºñ±Ý¼Ó
  • base runner
    ÁÖÀÚ
  • base running
    ÁÖ·ç
  • base stealing
    µµ·ç
  • base umpire
    ´©½É
  • data base
    µ¥ÀÌÅͺ£À̽º(ÀüÀÚ°è»ê±â¿ë Á¤º¸ÀÇ ÃàÀû ¹× ÀÌ Á¤º¸ÀÇ Á¦°ø ¼­ºñ½º)
  • data base management system
    (Àü»ê)µ¥ÀÌÅͺ£À̽º °ü¸® ½Ã½ºÅÛ(¾à DBMS)
  • first base
    1·ç;1·çÀÇ À§Ä¡(¼öºñ)
  • first base
    ÀÏ·ç¼ö
  • forward base
    ÀüÁø±âÁö
  • free base
    ÇÁ¸® º£À̽º(ÄÚÄ«Àΰú ¿¡Å׸£ÀÇ È¥ÇÕ¹°)
  • full base
    ¸¸·ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á